Clinical Trials Browser

Phase 1 × INDUSTRY × margetuximab × Clear all

NCT01148849 2025-02-26

Safety Study of MGAH22 in HER2-positive Carcinomas

Phase 1 Completed

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms